KR-336

N/A

Report date: 2025/03/17 15:02:20

Base Information

Drug NameKR-336
Drug Alias NameKR-336
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionProtein synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKernal Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKernal Biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A